This is a type of cancer that starts in the cells that line glands. It often grows into finger-like projections. It's a common type of thyroid cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Thyroid Surgery for Papillary Carcinoma?
Papillary carcinoma is a cancer named for the way its cells look under a microscope: they grow in small, finger-like projections. The name describes a growth pattern rather than one disease. The same pattern appears in cancers of different organs, and how the cancer behaves depends mainly on where it started. Most often, papillary carcinoma means papillary thyroid cancer. It starts in the thyroid, the butterfly-shaped gland at the front of the neck that makes hormones controlling metabolism, and it accounts for about 8 in 10 thyroid cancers. It usually grows very slowly, often stays in one side (lobe) of the gland, and sometimes spreads to lymph nodes in the neck. Most people with it can be cured. The pattern also occurs elsewhere. Papillary renal cell carcinoma makes up about 15 percent of renal cell carcinoma, the most common kidney cancer. In the bladder, papillary tumors grow from the inner lining toward the hollow center. Because kidney and bladder cancers are diagnosed and treated very differently from thyroid cancer, most of this page describes the thyroid form and notes where the others differ.
For most people with papillary thyroid cancer, no single cause can be identified. The clearest known risk factor is radiation to the head and neck during infancy or childhood, from medical treatment or from radioactive fallout; the cancer can appear as soon as five years after exposure. Risk is also higher in women, in people between about 25 and 65, in people of Asian descent, and in those with a past goiter (an enlarged thyroid) or a family history of thyroid disease or thyroid cancer. These factors raise the odds, but most people who have them never develop thyroid cancer, and many people who do have none of them. Papillary kidney cancer usually occurs by chance. Rare inherited forms run in families, including hereditary papillary renal carcinoma and hereditary leiomyomatosis and renal cell carcinoma (HLRCC), which can also cause skin growths and early uterine fibroids. Smoking, excess body weight and high blood pressure raise the risk of kidney cancer in general.
Papillary thyroid cancer often first appears as a lump in the neck, or it is found by chance during an exam or a scan done for another reason. Thyroid lumps (nodules) are common, and most are not cancer. An ultrasound shows the size of a nodule and whether it is solid or filled with fluid. If a nodule looks suspicious, a fine-needle aspiration biopsy uses a thin needle, usually guided by ultrasound, to draw out cells for a pathologist to examine. Blood tests such as thyroid-stimulating hormone (TSH) show how the gland is working but cannot diagnose cancer on their own. Sometimes the diagnosis is confirmed only after a surgeon removes a lobe of the thyroid. Because thyroid cancer types can be hard to tell apart, it helps to have samples read by a pathologist experienced with thyroid cancer. Before surgery, a doctor may look at the vocal cords with a thin scope (laryngoscopy) to check that they move normally. Staging for papillary thyroid cancer depends on age. In people younger than 55, it is stage I even if it has reached nearby lymph nodes, and stage II only if it has spread to distant sites such as the lungs or bones. From age 55, size and spread into neck tissues carry more weight. Papillary kidney cancer is usually found on imaging such as a CT (computed tomography) scan, MRI (magnetic resonance imaging) or ultrasound, sometimes after blood in the urine, and a needle biopsy can confirm the type. Papillary bladder tumors are examined, and often removed, with a thin lighted scope (cystoscope) passed into the bladder through the urethra.
Surgery is the main treatment for papillary thyroid cancer. For a small cancer that has not spread beyond the thyroid, removing only the affected lobe (lobectomy) may be enough, and many people keep enough thyroid function to avoid daily hormone pills. Larger or more extensive cancers are usually treated by removing the whole gland (total thyroidectomy), sometimes along with nearby lymph nodes. After a total thyroidectomy, people take a thyroid hormone pill, levothyroxine (such as Synthroid), every day for life. The main surgical risks are hoarseness from injury to a nerve that controls the voice and low blood calcium from injury to the parathyroid glands, small glands behind the thyroid that regulate calcium. Radioactive iodine is a pill or liquid that thyroid cells absorb, so it can destroy thyroid tissue left after surgery and cancer cells that have spread, with little effect on other tissues. It is used for some papillary cancers, particularly those at higher risk of coming back, but its benefit is less clear for small cancers that have not spread. Preparation usually involves a low-iodine diet for one to two weeks and raising TSH, either by stopping thyroid hormone for a time or with injections of a lab-made form of TSH (Thyrogen). Afterward, people follow instructions for a period to limit radiation exposure to others, and common short-term effects include dry mouth, salivary gland swelling and taste changes. For some very small, low-risk papillary cancers (under 1 centimeter), current US guidelines give more room to lobectomy or to active surveillance, which means regular ultrasound checks instead of immediate surgery, with surgery if the cancer grows. Studies of surveillance show that most of these tumors change little, but the evidence is mostly observational and longest-standing in Japan. When papillary thyroid cancer has spread to the lungs or bones, treatment usually aims to control it rather than cure it. Radioactive iodine is used if the cancer still absorbs iodine. If it does not, targeted drugs such as sorafenib or lenvatinib, which block signals tumors use to grow, are options, alongside surgery or external radiation for specific sites. Papillary kidney and bladder cancers do not respond to radioactive iodine. Kidney tumors are usually treated with surgery, while noninvasive papillary bladder tumors are often removed with a scope passed through the urethra and then followed closely.
Most people treated for papillary thyroid cancer return to ordinary life. Recovery from thyroid surgery usually takes about four to six weeks, and many people go home the same day or the next. For those taking levothyroxine, the dose is adjusted with blood tests until it is right. Sometimes doctors deliberately keep TSH low, because TSH can encourage remaining cancer cells to grow; this is usually reserved for higher-risk cancers, since higher hormone doses over years can cause a fast or irregular heartbeat and thinning bones. Outlook is generally excellent. US cancer registry data show that people with papillary thyroid cancer confined to the thyroid or nearby lymph nodes live about as long over five years as people without it. When the cancer has spread to distant organs, about 7 in 10 are alive five years after diagnosis. Because papillary thyroid cancer grows slowly, it can come back even 10 to 20 years later, usually in the neck. Follow-up therefore continues for years, with neck ultrasounds and, after a total thyroidectomy, blood tests for thyroglobulin, a protein made only by thyroid cells that acts as a marker for remaining or returning cancer. For people at low risk, follow-up becomes less frequent over time. The outlook for papillary kidney cancer depends on its type and stage: type 1 tends to grow slowly, while type 2 is more aggressive. Low-grade papillary bladder tumors rarely invade the bladder wall but often come back, so regular bladder checks are part of life after treatment.
Arrange a medical visit for a lump in the neck, a change in your voice or hoarseness that does not go away, or trouble swallowing. These have many causes other than cancer, but they are worth checking. Blood in the urine also deserves prompt evaluation, since it can signal kidney or bladder problems, including papillary tumors. After thyroid surgery, contact your surgeon promptly for numbness or tingling in the face or lips, or muscle spasms, which can mean low calcium, and for bleeding, redness or swelling at the incision, a fever of 100.5°F (38°C) or higher, a weak voice or difficulty eating. If you have been treated before, tell your care team about a new lump in the neck or a rising thyroglobulin result, since either can be an early sign of recurrence.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Papillary Carcinoma is like, what's helped you, or ask the community a question.